Sign in to view content

Episode 32 - Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander

Keyvan Koushan, MD, FRCSC

Audio
Published 2020

Related

Real-World Rates of Suspected Endophthalmitis Following Anti-VEGF and Steroid Intravitreal Injections in the US
Dilsher S. Dhoot, MD
Annual Meeting Talks
2019
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
2022
Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021

Category: Pharmacology-AntiVEGF

See more